Adverum Biotechnologies (ADVM) EBITDA (2013 - 2025)
Adverum Biotechnologies (ADVM) EBITDA from Jun 30, 2013 to Sep 30, 2025. The TTM Adverum Biotechnologies (ADVM) EBITDA is -$189M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Adverum Biotechnologies (ADVM) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +55.62% |
| 3 Years TTM | +16.13% |
| 5 Years TTM | +14.07% |
| 10 Years TTM | +15.83% |
| All Time TTM | +34.37% |
Annual EBITDA change of Adverum Biotechnologies (ADVM)
| Year | EBITDA | Change |
|---|---|---|
| 2025 | -$144M | +6.55% |
| 2024 | -$136M | +9.90% |
| 2023 | -$123M | -18.13% |
| 2022 | -$151M | +6.45% |
| 2021 | -$141M | +24.33% |
| 2020 | -$114M | +69.91% |
| 2019 | -$67M | -12.26% |
| 2018 | -$76M | +34.50% |
| 2017 | -$57M | -50.08% |
| 2016 | -$114M | +141.82% |
| 2015 | -$47M | +93.94% |
| 2014 | -$24M | +606.71% |
| 2013 | -$3.43M | +89.50% |
| 2012 | -$1.81M | N/A |
Comparison Adverum Biotechnologies (ADVM) five years EBITDA CAGR with competitors
Adverum Biotechnologies (ADVM) five years EBITDA CAGR is 14.07%.